glp 1 pills eli lilly The FDA approved a new GLP-1 pill from on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Eli Lilly stock soars on

Calibrate, which began prescribing anti-obesity medications in 2020 as part of a weight loss program, prominently describes the drugs as a "temporary aid to improve your metabolic health." In Denmark, a venture-backed startup, Embla, says on its website that it offers GLP-1s "always with the clear aim of a healthy transition off medication once you've reached your goals." (Other companies, including the weight-loss giant WeightWatchers and more recent incumbents such as Ro, have begun dabbling in GLP-1 medications, too, though they are clear in their messaging that these drugs are meant to be taken long-term.) A spokeswoman for Noom frames the issue as partly one of customer demand: When asked about the company's marketing of Ozempic as a drug to take for a limited time, she emphasized that most patients don't want to stay on the medications forever, noting that research showing that "68% of people stop taking the GLP-1 by month 12 suggests a reticence to a forever medication by many

Novo Nordisk's pipeline could help it bounce back as it launches newer, better products in its core therapeutic area and elsewhere, and improves its financial results

CAN YOU TAKE TOO MUCH B12

doi: 10.1007/s00394-015-1104-x